Cargando…
Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source
High‐dose‐rate (HDR) brachytherapy is a popular modality for treating cancers of the prostate, cervix, endometrium, breast, skin, bronchus, esophagus, and head and neck as well as soft‐tissue sarcomas. Because of different source designs and licensing issues, there is a need for specific dosimetry d...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874862/ https://www.ncbi.nlm.nih.gov/pubmed/27074483 http://dx.doi.org/10.1120/jacmp.v17i2.6005 |
_version_ | 1783310247869284352 |
---|---|
author | Ayoobian, Navid Asl, Akbar Sarabi Poorbaygi, Hosein Javanshir, Mohammad Reza |
author_facet | Ayoobian, Navid Asl, Akbar Sarabi Poorbaygi, Hosein Javanshir, Mohammad Reza |
author_sort | Ayoobian, Navid |
collection | PubMed |
description | High‐dose‐rate (HDR) brachytherapy is a popular modality for treating cancers of the prostate, cervix, endometrium, breast, skin, bronchus, esophagus, and head and neck as well as soft‐tissue sarcomas. Because of different source designs and licensing issues, there is a need for specific dosimetry dataset for each HDR source model. The main objective of the present work is to measure 2D relative dose distribution around a new prototype [Formula: see text] source, referred to as IRAsource‐HDR, in PMMA phantom in the framework of AAPM TG‐43 and TG‐55 recommendations for radial distances of 0.5 cm to 4 cm. Radiochromic films (RCFs) Gafchromic EBT and HD‐810 were used for measurements. The dose rate constant, Λ, of the source was determined to be [Formula: see text] , and [Formula: see text] using EBTRCF, HD‐810 RCF, and Monte Carlo (MC) simulation, respectively. The results obtained in this study are in good agreement with previously published data for HDR interstitial [Formula: see text] ‐HDR sources with a maximum discrepancy of [Formula: see text]. An acceptable agreement (within [Formula: see text]) between MC calculations and RCFs measurements showed that HD‐810 RCF dosimetry is as good as EBTRCF, within HDR brachytherapy, and justifies the use of specific data for this new source. These data could be used as a benchmark for dose calculations in the conventional brachytherapy treatment planning systems. PACS number(s): 87.56.bg |
format | Online Article Text |
id | pubmed-5874862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-58748622018-04-02 Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source Ayoobian, Navid Asl, Akbar Sarabi Poorbaygi, Hosein Javanshir, Mohammad Reza J Appl Clin Med Phys Radiation Oncology Physics High‐dose‐rate (HDR) brachytherapy is a popular modality for treating cancers of the prostate, cervix, endometrium, breast, skin, bronchus, esophagus, and head and neck as well as soft‐tissue sarcomas. Because of different source designs and licensing issues, there is a need for specific dosimetry dataset for each HDR source model. The main objective of the present work is to measure 2D relative dose distribution around a new prototype [Formula: see text] source, referred to as IRAsource‐HDR, in PMMA phantom in the framework of AAPM TG‐43 and TG‐55 recommendations for radial distances of 0.5 cm to 4 cm. Radiochromic films (RCFs) Gafchromic EBT and HD‐810 were used for measurements. The dose rate constant, Λ, of the source was determined to be [Formula: see text] , and [Formula: see text] using EBTRCF, HD‐810 RCF, and Monte Carlo (MC) simulation, respectively. The results obtained in this study are in good agreement with previously published data for HDR interstitial [Formula: see text] ‐HDR sources with a maximum discrepancy of [Formula: see text]. An acceptable agreement (within [Formula: see text]) between MC calculations and RCFs measurements showed that HD‐810 RCF dosimetry is as good as EBTRCF, within HDR brachytherapy, and justifies the use of specific data for this new source. These data could be used as a benchmark for dose calculations in the conventional brachytherapy treatment planning systems. PACS number(s): 87.56.bg John Wiley and Sons Inc. 2016-03-08 /pmc/articles/PMC5874862/ /pubmed/27074483 http://dx.doi.org/10.1120/jacmp.v17i2.6005 Text en © 2016 The Authors. This is an open access article under the terms of the http://creativecommons.org/licenses/by/3.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Ayoobian, Navid Asl, Akbar Sarabi Poorbaygi, Hosein Javanshir, Mohammad Reza Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source |
title | Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source |
title_full | Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source |
title_fullStr | Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source |
title_full_unstemmed | Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source |
title_short | Gafchromic film dosimetry of a new HDR [Formula: see text] brachytherapy source |
title_sort | gafchromic film dosimetry of a new hdr [formula: see text] brachytherapy source |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874862/ https://www.ncbi.nlm.nih.gov/pubmed/27074483 http://dx.doi.org/10.1120/jacmp.v17i2.6005 |
work_keys_str_mv | AT ayoobiannavid gafchromicfilmdosimetryofanewhdrformulaseetextbrachytherapysource AT aslakbarsarabi gafchromicfilmdosimetryofanewhdrformulaseetextbrachytherapysource AT poorbaygihosein gafchromicfilmdosimetryofanewhdrformulaseetextbrachytherapysource AT javanshirmohammadreza gafchromicfilmdosimetryofanewhdrformulaseetextbrachytherapysource |